CAP Partners »

Crispr Therapeutics shares owned by CAP Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by CAP Partners from 13F filings

Historical chart of CAP Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by CAP Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by CAP Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $205k 4.3k 47.57

More positions owned by CAP Partners

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Select Sector Spdr Tr State Street Rea (XLRE)
American Centy Etf Tr Avantis Us Small (AVSC)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Spdr Series Trust State Street Spd (SPYM)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for CAP Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics